Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Visconti

Showing results (11-20 of 87) with videos related to

Pageof 9
Sort By:
Bollettino Della Societa Italiana Di Biologia Sperimentale|October 15, 1976
[Effects of calcium-2,2'-disulfohexanoate on murine hepatitis due to MHV-3 virus]V Guadagnino, M Visconti, R Orlando, et al.
La Radiologia Medica|October 1, 1978
[Calculation of the maximum admissible concentrations of unclassified radionuclides used in nuclear medicine]G Pedroli, L Conte, G Inversini, et al.
Journal of Chromatography. B, Biomedical Applications|April 7, 1995
Determination of the polar drug dimiracetam in human plasma and serum by column-switching high-performance liquid chromatographyL Torchio, F Lombardi, M Visconti, et al.
Il Farmaco; Edizione Pratica|August 1, 1977
Physicochemical profile of a new antisecretory and antiulcer drug: trithiozineP Ventura, M Visconti, S Cocozza, et al.
Journal of Clinical Gastroenterology|October 1, 1995
Recurrence of acute fatty liver of pregnancyM Visconti, G Manes, F Giannattasio, et al.
Journal of Chromatography|September 14, 1984
High-performance liquid chromatographic separation of cadralazine from its potential metabolites and degradation products. Quantitation of the drug in human plasma and urineT Crolla, F Santini, M Visconti, et al.
Journal of Pharmaceutical Sciences|December 1, 1984
Degradative behavior of cadralazine in aqueous solutionM Visconti, L Citerio, M Borsa, et al.
Journal of Chromatography|April 15, 1992
High-performance liquid chromatographic determination of rufloxacin and its main active metabolite in biological fluidsF Lombardi, R Ardemagni, V Colzani, et al.
Bollettino Della Societa Italiana Di Biologia Sperimentale|February 28, 1973
[Persistence of antibodies inhibiting hemagglutination by influenza viruses in aged vaccinated women. Changes in antibody titer after re-vaccination]M Visconti, F Verde, G Frezza, et al.
European Journal of Drug Metabolism and Pharmacokinetics|October 1, 1988
Pharmacokinetics of cadralazine in hypertensive patientsG Leonetti, J Parini, M Visconti, et al.
Pageof 9

Showing results (11-20 of 87) with videos related to

Sort By:
Pageof 9
Bollettino Della Societa Italiana Di Biologia Sperimentale|October 15, 1976
[Effects of calcium-2,2'-disulfohexanoate on murine hepatitis due to MHV-3 virus]V Guadagnino, M Visconti, R Orlando, et al.
La Radiologia Medica|October 1, 1978
[Calculation of the maximum admissible concentrations of unclassified radionuclides used in nuclear medicine]G Pedroli, L Conte, G Inversini, et al.
Journal of Chromatography. B, Biomedical Applications|April 7, 1995
Determination of the polar drug dimiracetam in human plasma and serum by column-switching high-performance liquid chromatographyL Torchio, F Lombardi, M Visconti, et al.
Il Farmaco; Edizione Pratica|August 1, 1977
Physicochemical profile of a new antisecretory and antiulcer drug: trithiozineP Ventura, M Visconti, S Cocozza, et al.
Journal of Clinical Gastroenterology|October 1, 1995
Recurrence of acute fatty liver of pregnancyM Visconti, G Manes, F Giannattasio, et al.
Journal of Chromatography|September 14, 1984
High-performance liquid chromatographic separation of cadralazine from its potential metabolites and degradation products. Quantitation of the drug in human plasma and urineT Crolla, F Santini, M Visconti, et al.
Journal of Pharmaceutical Sciences|December 1, 1984
Degradative behavior of cadralazine in aqueous solutionM Visconti, L Citerio, M Borsa, et al.
Journal of Chromatography|April 15, 1992
High-performance liquid chromatographic determination of rufloxacin and its main active metabolite in biological fluidsF Lombardi, R Ardemagni, V Colzani, et al.
Bollettino Della Societa Italiana Di Biologia Sperimentale|February 28, 1973
[Persistence of antibodies inhibiting hemagglutination by influenza viruses in aged vaccinated women. Changes in antibody titer after re-vaccination]M Visconti, F Verde, G Frezza, et al.
European Journal of Drug Metabolism and Pharmacokinetics|October 1, 1988
Pharmacokinetics of cadralazine in hypertensive patientsG Leonetti, J Parini, M Visconti, et al.
Pageof 9